期刊文献+

miR-204对乳腺癌MCF-7细胞增殖及凋亡的影响

Effect of miR-204 on proliferation and apoptosis of breast cancer cell line MCF-7
下载PDF
导出
摘要 目的探讨miR-204在人乳腺癌组织及MCF-7细胞中的表达水平及其对乳腺癌细胞增殖及凋亡的影响。方法提取癌症和肿瘤基因组图谱(the cancer genome atlas,TCGA)数据库中浸润性乳腺癌的miR-204相关数据进行汇总,转染miR-204过表达病毒,筛选稳定转染细胞株并通过RT-q PCR检测转染率,MTT法检测过表达miR-204后乳腺癌MCF-7细胞的增殖情况,流式细胞仪检测细胞凋亡情况。结果 miR-204在浸润性乳腺癌组织中的表达水平较癌旁组织明显下调(P<0.001),且与淋巴结转移和远处转移相关(P<0.05)。过表达miR-204能够抑制乳腺癌MCF-7细胞的增殖能力(P<0.05);miR-204上调后,细胞凋亡率达到(34.7±1.9)%,细胞凋亡能力明显增强(P<0.001)。结论 miR-204可抑制乳腺癌细胞增殖并介导细胞凋亡。 Objective To explore the expression of miR-204 in human breast cancer tissues and the MCF-7 cell line ,and to investigate the influence of miR-204 on proliferation and apoptosis of breast cancer cells. :Methods The miR-204 sequence was cloned based on information in the TCGA database, then it was used to generate recombinant virus and than transfected into MCF-7 cell,and the expressed microRNA was detected in infected cells using RT-qPCR. The proliferative ability of infected cells expressing miR-204 was tested using the MTF assay. Flow cytometry analysis was used to determine extent of apoptosis. Results Expression of miR-204 was significantly lower in invasive breast cancer tissues than in normal breast tissue;expression correlated with lymph node and cancer metastasis. MTT assays showed that overexpression of miR-204 inhibited MCF-7 cell proliferation, and flow cytometry suggested that it significantly increased the rate of apoptosis. Conclusion miR-204 can inhibit breast cancer cell proliferation and induce apoptosis.
出处 《中国癌症防治杂志》 CAS 2016年第2期83-87,共5页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
关键词 乳腺肿瘤 miR-204 乳腺癌MCF-7细胞株 增殖 凋亡 Breast neoplasm miR-204 Breast cancer cell line MCF-7 Proliferation Apoptosis
  • 相关文献

参考文献20

  • 1廖立,奉水东.miR-221/miR-222与肿瘤[J].中国癌症防治杂志,2014,6(4):408-411. 被引量:2
  • 2Torre LA,Bray F,Siegel RL,et al.Global cancer statistics 2012 [J]. CA Cancer J Clin,2015,65(2) :87-108.
  • 3World Health Organization.GLOBOCAN 2012.[EB/OL].[2014-11 ]. http ://globocan.iarc.fr/Defauh.aspx.
  • 4Chen W, Zheng R, B aade PD, et al.Cancer statistics in China, 2015 [ J ]. CA Cancer J Clin,2016,66(2) : 115-132.
  • 5Di Leva G,Garofalo M,Croce C M.MicroRNAs in cancer [J].Annu Rev Pathol, 2014,9: 287-314.
  • 6Hausser J,Zavolan M.Identification and consequences of miRNA- target interactions-beyond repression of gene expression[J].Nat Rev Genet, 2014,15(9) : 599-612.
  • 7Iorio MV,Casalini P,Piovan C,et al.Breast cancer and microRNAs: therapeutic impact [J].Breast, 2011,20(Suppl 3 ) : S63-70.
  • 8Dinami R,Ercolani C,Petti E,et al.miR-155 drives telomere fragility in human breast cancer by targeting TRF1 [J].Cancer Res,2014,74 ( 15 ) :4145-4156.
  • 9Huang Q, Gumireddy K,Schrier M, et al.The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis[J].Nat Cell Biol, 2008,10(2) :202-210.
  • 10Fu J,Xu X,Kang L,et al.MiR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2[J].Biochem Biophys Res Commun, 2014,445(2) : 314-319.

二级参考文献30

  • 1Dettmer MS, Perren A, Moch H,et al.MicroRNA profile of poorlydifferentiated thyroid carcinomas : new diagnostic and prognostic in-aights[ J ] Journal of Molecular Endocrinology,2014,52(2) : 181-189.
  • 2Miller TE,Ghoshal K,Ramaswamy B,et al.MicroRNA-221/222 con-fers tamoxifen resistance in breast cancer by targeting p27Kipl [j].The Journal of Biological Chemistry, 2008,283 ( 44 ) : 29897-28903.
  • 3Karakatsanis A,Papaconstantinou I,Gazouli M, et al. Expression ofmicroRNAs,miR-21,miR-31, miR-122, miR-145,miR- 146a,miR-200c,miR-221, miR-222, and miR-223 in patients with hepatocellularcarcinoma or intxahepatic cholangiocarcinoma and its prognosticsignificance[j].Molecular Carcinogenesis,2013,52(4) : 297-303.
  • 4Zhang C,Zhang J,Hao J,et al.High level of miR-221 /miR-222 con-fers increased cell invasion and poor prognosis in glioma[J].Journalof Translational Medicine,2012,10: 119.
  • 5Papaconstantinou IG,Manta A, Gazouli M,et al.Expression of mi ?croRNAs in patients with pancreatic cancer and its prognostic sig-nificance [ J ] .Pancreas ,2013,42( 1) :67-71.
  • 6Wang M,Zhao C,Shi H,et al.Deregulated microRNAs in gastriccancer tissue-derived mesenchymal stem cells : novel biomarkers anda mechanism for gastric cancer[J].British Journal of Cancer,2014,110(5):1199-1210.
  • 7Koelz M,Lense J,Wrba F,et al.Down-regulation of miR-221 andmiR-222 correlates with pronounced Kit expression in gastrointesti-nal stromal tumors[ J ].International Journal of Oncology,2011,38(2):503-511.
  • 8Tong AW,Fulgham P,Jay C,et al.MicroRNA profile analysis ofhuman prostate cancers [ J ] .Cancer gene Therapy, 2009,16(3): 206-216.
  • 9Pu XX,Huang GL, Guo HQ,et al.Circulating miR-221 directly am- plified from plasma is a potential diagnostic and prognostic marker of co[orectal cancer and is correlated with p53 expression[J].Joumal of Gastroenterology and Hepatology,2010,25(10) : 1674-1680.
  • 10Teixeira AL,Ferreira M,Silva J,et al.Higher circulating expressionlevels of miR-221 associated with poor overall survival in renal cellcarcinoma patients[J].Tumour Biol,2014,35(5):4057-4066.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部